BILAWISH-M
Bilastine and Montelukast Tablet
BILAWISH-M from Bioglint Derma Care contains Bilastine and Montelukast, a combination of two medicines that help manage allergy-related symptoms. It works by blocking the effects of histamine and leukotrienes, which are substances in the body that cause allergic reactions and inflammation. The product is available in tablet form and is part of Bioglint Derma Care’s pharmaceutical product range.
Bilastine helps reduce allergy symptoms such as sneezing, a runny nose, itchy eyes and skin itching. Montelukast helps control the effects of leukotrienes, which play a role in allergic reactions and breathing-related symptoms. Together, these medicines help manage certain allergic conditions. The exact use depends on the patient’s condition and the doctor’s advice.
BILAWISH-M may be prescribed by a qualified healthcare professional for patients who need treatment for certain allergic conditions. The dosage and duration of treatment depend on the patient’s age, medical condition, response to treatment and the doctor’s recommendation.
Bilastine and Montelukast Tablets PCD Pharma Franchise Opportunity with Bioglint Derma Care
Bioglint Derma Care offers a range of pharmaceutical products for dermatology and related healthcare needs. BILAWISH-M can be a useful addition for eligible pharma professionals looking to expand their product portfolio with a combination of Bilastine and Montelukast.
The product is suitable for pharma distributors, stockists, medical representatives and other eligible professionals interested in growing their pharmaceutical business through the PCD Pharma Franchise model. For pharma professionals looking to expand their product portfolio, BILAWISH-M offers a combination formulation containing Bilastine and Montelukast for prescribed medical use.
If you are looking for a Bilastine and Montelukast Tablets PCD Pharma Franchise, BILAWISH-M can be considered as part of your pharmaceutical portfolio. Contact Bioglint Derma Care for current information about product availability, territory options, franchise requirements, pricing, packaging and business terms.
Why Choose BILAWISH-M for Your Franchise Portfolio?
- Contains a combination of Bilastine and Montelukast.
- Helps manage symptoms associated with allergic conditions.
- Bilastine helps relieve sneezing, itching and runny nose.
- Montelukast helps control the effects of allergy-related inflammatory substances.
- Available in tablet form for oral use.
- Suitable for inclusion in an allergy and respiratory care product portfolio.
- Part of Bioglint Derma Care’s pharmaceutical product range.Partner with Bioglint Derma Care
Product Details
Product – BILAWISH-M
Composition – Bilastine and Montelukast
Dosage Form – Tablet
Packing – 10×10
Category – Anti-Allergic / Allergy Care
Company – Bioglint Derma Care
Business Opportunity – PCD Pharma Franchise
Disclaimer – BILAWISH-M (Bilastine and Montelukast Tablets) should be used only under the supervision of a qualified healthcare professional. Montelukast has important warnings, including possible mood and behaviour-related side effects. Do not start, stop or change the dose without consulting your doctor. Always follow the prescribed dosage and approved product information.
